#Coronavirus

923 Cases Of Covid Sub-Variant JN.1 Reported From 15 States
#Coronavirus

India's Active Covid Cases Rise Above 4,000; Thane Reports 5 JN.1 Variant Infections
#Coronavirus

As COVID-19 Cases Rise, WHO Asks Countries To Strengthen Surveillance
#Coronavirus

COVID JN.1 Variant Spreading Rapidly, But Not Causing Severe Infections, Says Ex-AIIMS Director
#Coronavirus

India Reports 752 New COVID-19 Cases; Country's Active Cases At 3,420
#Coronavirus

Covid Updates: India Sees 22 JN.1 Cases With Mild Symptoms, Kerala Health Minister Warns Of Surge

Smoking, COPD linked with higher death risk from COVID-19: Study

By PTI

| Updated: Wednesday, May 13, 2020, 9:15 [IST]

London, May 12: Being a current smoker or having chronic obstructive pulmonary disease (COPD) are associated with an increased risk of severe complications and higher death risk from COVID-19 infection, according to a study.

COPD is a common, persistent dysfunction of the lung associated with a limitation in airflow.

The researchers from the University College London in the UK noted that an estimated 251 million people worldwide are affected by COPD.

Given the effects of the SARS-CoV-2 coronavirus on respiratory function, they sought to understand the prevalence and the effects of COPD in COVID-19 patients.

Vitamin D linked to low coronavirus death rate in European countries: Study Vitamin D linked to low coronavirus death rate in European countries: Study

The study, published in the journal PLOS ONE, systematically searched databases of scientific literature to find existing publications on the epidemiological, clinical characteristics and features of COVID-19, and the prevalence of COPD in COVID-19 patients.

As many as 123 potentially relevant papers were narrowed to 15 that met all quality and inclusion guidelines, the researchers said. The included studies had a total of 2,473 confirmed COVID-19 patients, they said.

The study found that critically ill COVID-19 patients with COPD had a 63 per cent risk of severe disease and a 60 per cent risk of mortality. On the other hand, critically ill patients without COPD had only a 33.4 per cent risk of severe disease, and 55 per cent risk of mortality, the researchers said.

Current smokers were also 1.45 times more likely to have severe complications compared to former and never smokers, they said. The study was not able to examine whether there was an association between the frequency of COPD exacerbations, or severity of COPD, with COVID-19 outcomes or complications.

ICMR to study prevalence of asymptomatic COVID-19 infected people to check for community spread ICMR to study prevalence of asymptomatic COVID-19 infected people to check for community spread

The researchers noted that the results are limited by the fact that few studies were available to review, as well as the diverse locations, settings, and designs of the included studies.

"Despite the low prevalence of COPD and smoking in COVID-19 cases, COPD and current smokers were associated with greater COVID-19 severity and mortality," the researchers added.